Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes"

Clinical trial NCT05305794 · RECRUITING

Trial details

NCT number: NCT05305794
Sponsor: Centre Hospitalier Universitaire Dijon
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Double Diabetes

Start date: 2022-07-12
Primary completion: 2028-08-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.